Dr. Berdis’s research focuses on developing better treatments for brain cancer, the deadliest of all cancers. His group’s development of an improvement to an FDA-approved drug used to treat brain cancer was featured on News 5 Cleveland in January, and his team is currently performing in-depth safety studies on this compound in order to pursue a Phase I clinical trial within the next two years.